In vitro activity of piperacillin/tazobactam and ertapenem against Bacteroides fragilis and Escherichia coli in pure and mixed cultures. 2007

Kênia Valéria Dos Santos, and Cláudio Galuppo Diniz, and Simone Cristina Coutinho, and Ana Carolina Morais Apolônio, and Luciana Geralda de Sousa-Gaia, and Jacques Robert Nicoli, and Luiz de Macêdo Farias, and Maria Auxiliadora Roque de Carvalho
Departamento de Microbiologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.

Ertapenem and piperacillin/tazobactam are beta-lactam antibiotics with a broad spectrum of activity used for the treatment of mixed infections in which Bacteroides fragilis and Escherichia coli play an important aetiological role. In this study, the activities of piperacillin/tazobactam and ertapenem (MIC and time-kill kinetics) against these bacteria were compared. MICs were determined by the agar dilution method, and the time and slope of time-kill curves were analysed. In the in vitro pharmacodynamic assays, pure and mixed cultures of E. coli and B. fragilis were exposed to peak concentrations of ertapenem (8.0 microg ml(-1)) and piperacillin/tazobactam (64.0/8.0 microg ml(-1)) for 48 h. Treatment with ertapenem reduced the viability of E. coli and/or B. fragilis by 3 logs in all experiments, whereas piperacillin/tazobactam only affected the viability of B. fragilis. Both drugs exhibited their fastest rates of killing when bacteria were grown in mixed cultures. According to the results, ertapenem exhibited activity similar to that of piperacillin/tazobactam against B. fragilis alone or in mixed culture. However, ertapenem exhibited a markedly higher activity against E. coli alone or in combination with B. fragilis relative to piperacillin/tazobactam.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D010397 Penicillanic Acid A building block of penicillin, devoid of significant antibacterial activity. (From Merck Index, 11th ed) Acid, Penicillanic
D010878 Piperacillin Semisynthetic, broad-spectrum, AMPICILLIN derived ureidopenicillin antibiotic proposed for PSEUDOMONAS infections. It is also used in combination with other antibiotics. AB-Piperacillin,Cl-227193,Pipcil,Pipera-Hameln,Piperacillin Curasan,Piperacillin Fresenius,Piperacillin Hexal,Piperacillin Monosodium Salt,Piperacillin Sodium,Piperacillin-Ratiopharm,Pipercillin,Pipracil,Pipril,T-1220,T1220,AB Piperacillin,Cl 227193,Cl227193,Curasan, Piperacillin,Monosodium Salt, Piperacillin,Pipera Hameln,Piperacillin Ratiopharm,Salt, Piperacillin Monosodium,Sodium, Piperacillin,T 1220
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D000077725 Piperacillin, Tazobactam Drug Combination An antibiotic combination product of piperacillin and tazobactam, a penicillanic acid derivative with enhanced beta-lactamase inhibitory activity, that is used for the intravenous treatment of intra-abdominal, pelvic, and skin infections and for community-acquired pneumonia of moderate severity. It is also used for the treatment of PSEUDOMONAS AERUGINOSA INFECTIONS. Piperacillin - Tazobactam,Piperacillin-Tazobactam Combination Product,Pipercillin Sodium - Tazobactam Sodium,Pipercillin Sodium, Tazobactam Sodium Drug Combination,Tazocel,Tazocillin,Tazocin,Zosyn,Piperacillin Tazobactam,Piperacillin Tazobactam Combination Product,Pipercillin Sodium Tazobactam Sodium,Tazobactam, Piperacillin -
D000077727 Ertapenem A carbapenem derivative antibacterial agent that is more stable to renal dehydropeptidase I than IMIPENEM, but does not need to be given with an enzyme inhibitor such as CILASTATIN. It is used in the treatment of Gram-positive and Gram-negative bacterial infections including intra-abdominal infections, acute gynecological infections, complicated urinary tract infections, skin infections, and respiratory tract infections. It is also used to prevent infection in colorectal surgery. Ertapenem Sodium,Invanoz,Invanz
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001441 Bacteroides fragilis Gram-negative bacteria occurring in the lower intestinal tracts of man and other animals. It is the most common species of anaerobic bacteria isolated from human soft tissue infections.
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D015169 Colony Count, Microbial Enumeration by direct count of viable, isolated bacterial, archaeal, or fungal CELLS or SPORES capable of growth on solid CULTURE MEDIA. The method is used routinely by environmental microbiologists for quantifying organisms in AIR; FOOD; and WATER; by clinicians for measuring patients' microbial load; and in antimicrobial drug testing. Agar Dilution Count,Colony-Forming Units Assay, Microbial,Fungal Count,Pour Plate Count,Spore Count,Spread Plate Count,Streak Plate Count,Colony Forming Units Assay, Microbial,Colony Forming Units Assays, Microbial,Agar Dilution Counts,Colony Counts, Microbial,Count, Agar Dilution,Count, Fungal,Count, Microbial Colony,Count, Pour Plate,Count, Spore,Count, Spread Plate,Count, Streak Plate,Counts, Agar Dilution,Counts, Fungal,Counts, Microbial Colony,Counts, Pour Plate,Counts, Spore,Counts, Spread Plate,Counts, Streak Plate,Dilution Count, Agar,Dilution Counts, Agar,Fungal Counts,Microbial Colony Count,Microbial Colony Counts,Pour Plate Counts,Spore Counts,Spread Plate Counts,Streak Plate Counts

Related Publications

Kênia Valéria Dos Santos, and Cláudio Galuppo Diniz, and Simone Cristina Coutinho, and Ana Carolina Morais Apolônio, and Luciana Geralda de Sousa-Gaia, and Jacques Robert Nicoli, and Luiz de Macêdo Farias, and Maria Auxiliadora Roque de Carvalho
August 2005, Journal of medical microbiology,
Kênia Valéria Dos Santos, and Cláudio Galuppo Diniz, and Simone Cristina Coutinho, and Ana Carolina Morais Apolônio, and Luciana Geralda de Sousa-Gaia, and Jacques Robert Nicoli, and Luiz de Macêdo Farias, and Maria Auxiliadora Roque de Carvalho
August 1988, The Journal of antimicrobial chemotherapy,
Kênia Valéria Dos Santos, and Cláudio Galuppo Diniz, and Simone Cristina Coutinho, and Ana Carolina Morais Apolônio, and Luciana Geralda de Sousa-Gaia, and Jacques Robert Nicoli, and Luiz de Macêdo Farias, and Maria Auxiliadora Roque de Carvalho
June 2002, Diagnostic microbiology and infectious disease,
Kênia Valéria Dos Santos, and Cláudio Galuppo Diniz, and Simone Cristina Coutinho, and Ana Carolina Morais Apolônio, and Luciana Geralda de Sousa-Gaia, and Jacques Robert Nicoli, and Luiz de Macêdo Farias, and Maria Auxiliadora Roque de Carvalho
November 1987, The Journal of antimicrobial chemotherapy,
Kênia Valéria Dos Santos, and Cláudio Galuppo Diniz, and Simone Cristina Coutinho, and Ana Carolina Morais Apolônio, and Luciana Geralda de Sousa-Gaia, and Jacques Robert Nicoli, and Luiz de Macêdo Farias, and Maria Auxiliadora Roque de Carvalho
July 1984, Antimicrobial agents and chemotherapy,
Kênia Valéria Dos Santos, and Cláudio Galuppo Diniz, and Simone Cristina Coutinho, and Ana Carolina Morais Apolônio, and Luciana Geralda de Sousa-Gaia, and Jacques Robert Nicoli, and Luiz de Macêdo Farias, and Maria Auxiliadora Roque de Carvalho
December 2012, Antimicrobial agents and chemotherapy,
Kênia Valéria Dos Santos, and Cláudio Galuppo Diniz, and Simone Cristina Coutinho, and Ana Carolina Morais Apolônio, and Luciana Geralda de Sousa-Gaia, and Jacques Robert Nicoli, and Luiz de Macêdo Farias, and Maria Auxiliadora Roque de Carvalho
December 2016, Antimicrobial agents and chemotherapy,
Kênia Valéria Dos Santos, and Cláudio Galuppo Diniz, and Simone Cristina Coutinho, and Ana Carolina Morais Apolônio, and Luciana Geralda de Sousa-Gaia, and Jacques Robert Nicoli, and Luiz de Macêdo Farias, and Maria Auxiliadora Roque de Carvalho
April 2004, Chemotherapy,
Kênia Valéria Dos Santos, and Cláudio Galuppo Diniz, and Simone Cristina Coutinho, and Ana Carolina Morais Apolônio, and Luciana Geralda de Sousa-Gaia, and Jacques Robert Nicoli, and Luiz de Macêdo Farias, and Maria Auxiliadora Roque de Carvalho
August 2013, Anaerobe,
Kênia Valéria Dos Santos, and Cláudio Galuppo Diniz, and Simone Cristina Coutinho, and Ana Carolina Morais Apolônio, and Luciana Geralda de Sousa-Gaia, and Jacques Robert Nicoli, and Luiz de Macêdo Farias, and Maria Auxiliadora Roque de Carvalho
January 1993, Infection,
Copied contents to your clipboard!